Scientists and technologists in India and the United States collaborated to identify a molecule that when applied to the fabric binds on it...

The latest capital raise will allow the company to complete its phase-1 studies for its GYROX series intravenous drug candidate, as well as...

The company plans to use the funds to deepen its clinical trials.

“We’re creating a bullet against organisms that are taking out humanity. Wouldn’t it be nice to get a battleground to test it on that’s rea...

PayNEARBY's Aadhaar ATM will be available through Yes Bank and the business correspondent agent network comprising 40,000 touch points.

These husband-wife pairs had everyone's eyes and attention following them across the room.

A-listers from the startup world, top ministers, doyens of tech world made it a night to remember.

"At a time where the business narrative is predominantly dominated by tech, it is so heartening to see the Economics Times giving a platfor...

Despite the complexities, long durations and dearth of money required for such research, several young companies are making a global impact...

As a woman dies in the US from a superbug infection likely caught in India, four domestic companies are taking up the cudgels in the area o...

He is devising a 12-week programme with entrepreneurfriend Anand Anandkumar, founder, Bugworks Research, to provide computer literacy.

This bio-cluster is situated not too far from the Indian Institute of Science (IISc), research-led university that is also generating start...

Indeed, strong bonds already exist between Silicon Valley and Bengaluru specifically, and between the Valley and India in general.

A life sciences or medical product company is yet to make it big anywhere in India, despite a startup culture that is 15 years old.

Across geographies, big pharmaceutical companies seem to have stepped back from research and development (R&D) for new drug discovery in th...

Nearly half a dozen startups trace their roots to the 25-year-old centre that led critical research in areas such as tuberculosis and malar...

Lifesciences startups in India are no longer risk averse, developing applications like fuel from seaweed and nanomedicine that shrinks tumo...